NEUROGESX (NASDAQ:NGSX)
8.45
+0.07 (0.84%)
| NEUROGESX (NASDAQ:NGSX) Delayed : |
| Previous Close |
$8.38 |
|
52 Week High |
$9.20 |
|
| Open |
$8.38 |
|
52 Week Low |
$0.89 |
| Day High |
$8.62 |
|
P/E |
N/A |
| Day Low |
$8.30 |
|
EPS |
$-1.23 |
| Volume |
150,820 |
|
|
|
| More NGSX Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on NGSX
-
Nov 17, 2009 08:59 AM
NeurogesX (NGSX) Higher On FDA Approval of Qutenza
-
Nov 6, 2009 07:39 AM
NeurogesX (NGSX) Posts Q3 Loss of 38C, Wider than Expected
-
Nov 5, 2009 03:42 PM
Trading Radar for 11/06: American International (AIG), Scripps (SNI), Suncor Energy (SU), Blackstone Group (BX) Report
-
Jul 24, 2009 09:42 AM
NeurogesX (NGSX) Announces Preliminary Results of FDA-Requested Qutenza Study
-
Jun 22, 2009 09:10 AM
Morning Movers 6/22: SUAI, AVII, NGSX, EMKR Higher; LNET, AEG, ALU, GTE Lower
View All Reports
StreetInsider Reports on NGSX by Category
-
Nov 19, 2009 01:33 PM
NeurogesX: Next Stop, U.S. Market
-
Nov 18, 2009 05:28 AM
BioMed News Bytes: GeoVax, Cerus, Discovery Labs, NeurogesX
-
Oct 14, 2009 04:16 AM
FDA Calendar Extreme Trades: 85 Single Digit Stocks
-
Oct 1, 2009 10:19 AM
The Top 25
-
Aug 6, 2009 05:28 AM
FDA Calendar Updates: NeurogesX, Thoratec
View All Blogs
Comments on NGSX
No comments are currently available.